Business Wire

VA-REGULA

3.4.2024 09:01:31 CEST | Business Wire | Press release

Share
Updated Regula Face SDK Blocks 99% of Presentation Attacks Via Electronic Devices

When it comes to verifying identity in remote scenarios, it’s generally through liveness checks that organizations try to ensure they are dealing with a real individual. Fraudsters are perfectly aware of this fact, and therefore seek to bypass verification using various tactics, predominantly presentation or injection attacks. The first type of fraud involves attempts to trick the system by presenting fake biometric traits, such as photos, videos, masks, etc. Injection attacks are done by inserting altered biometric data directly into the process of identity verification (IDV).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240403567119/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

A presentation attack scenario blocked by Regula Face SDK (Photo: Business Wire)

To help organizations secure remote IDV processes, Regula offers powerful technologies capable of detecting even the most sophisticated biometric fraud, including presentation and injection attacks. This latest update marks an advancement in Regula’s ability to detect certain types of spoofing attacks.

Enhanced security. Now, Regula Face SDK, a comprehensive solution for biometric verification, has reached a 99% rate in detecting and blocking presentation attacks done from electronic devices. Its anti-spoofing technology ensures that the face detected during the verification process is from an actively present and real person.

Streamlined user experience. Also, the new release of Regula Face SDK brings a new level of usability to biometric verification, thanks to the introduction of Passive Liveness technology. Utilizing neural networks trained on a diverse dataset, this technology verifies the genuine presence of an individual without any active participation from users (unlike Active Liveness) – the solution just requires them to take a selfie.

To obtain proper data for verification, i.e., a high-quality face image, Regula Face SDK uses an advanced image capture module that assesses image quality in real time, reducing the need for retakes. Followed by an instant liveness check, this approach significantly streamlines the overall verification process, making it faster and more user-friendly while maintaining high security standards.

“Remote onboarding is our new reality. More risky for organizations and definitely more preferable for users, it is about finding the perfect balance between security and convenience. The Passive Liveness feature is a delicate solution to this equation. It’s a very accessible single step for the user, improving user experience and elevating conversion rates. But that’s not all: Passive Authentication still ensures a high level of trustworthiness in the IDV process, as it effectively proves the presence and realness of an individual. Plus, for those who need ultimate security during onboarding or user verification, there is still the option of choosing Active Liveness, a more user-involving and robust technology for proving liveness,” says Ihar Kliashchou, Chief Technology Officer at Regula.

For the sake of greater convenience and faster interaction, the updated Regula Face SDK also supports face matching on mobile devices, without transmitting data to a server. Now, even if a smartphone is offline, it is still possible to compare a photo from a document with a selfie when identity verification is done not remotely, but on-site by an employee, for example in a bank when a client wants to open an account or get access to other financial services.

To learn more about the capabilities of the new version of Regula Face SDK, visit the official webpage.

About Regula

Regula is a global developer of forensic devices and identity verification solutions. With our 30+ years of experience in forensic research and the largest library of document templates in the world, we create breakthrough technologies in document and biometric verification. Our hardware and software solutions allow over 1,000 organizations and 80 border control authorities globally to provide top-notch client service without compromising safety, security or speed. Regula was repeatedly named a Representative Vendor in the Gartner® Market Guide for Identity Verification.

Learn more at www.regulaforensics.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240403567119/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press release

The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a

SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release

Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release

News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi

Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release

Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye